TAOK2 and metabolic dysfunction-associated steatotic liver disease: Together, these data suggest that TAOK2, in contrast to our previous studies on closely related kinases TAOK1 and TAOK3 (Xia et al. 2021, 2023), is not involved in the regulation of hepatocellular lipotoxicity or NAFLD susceptibility.